GeraClinic / NHS cancer waiting times / NHS Herefordshire And Worcestershire ICB / Breast Symptomatic
NHS Herefordshire And Worcestershire ICB: Breast Symptomatic — 62-Day Cancer Waits
In April 2026, 0.0% of breast symptomatic cancer patients in NHS Herefordshire And Worcestershire ICB started treatment within 62 days — 3 patients on this pathway. NHS target: 85%. Official NHS England data.
What is the Breast Symptomatic cancer waiting time in NHS Herefordshire And Worcestershire ICB?
As of April 2026, 0.0% of breast symptomatic cancer patients in NHS Herefordshire And Worcestershire ICB started treatment within 62 days of referral (0 of 3 patients, NHS target: 85%), per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
| Measure | Value | Context |
|---|---|---|
| Patients on pathway | 3 | April 2026 |
| Within 62 days | 0 | Started treatment in time |
| Breaches | 3 | Did not meet 62-day standard |
| 62-day standard met | 0.0% | NHS target: 85% |
| Status vs target | MISSED | Target is 85% |
Other cancer pathways in NHS Herefordshire And Worcestershire ICB
NHS Herefordshire And Worcestershire ICB Breast Symptomatic cancer waits: FAQs
- What is the 62-day cancer waiting time for Breast Symptomatic in NHS Herefordshire And Worcestershire ICB?
- In April 2026, 0.0% of breast symptomatic cancer patients in NHS Herefordshire And Worcestershire ICB started treatment within 62 days of referral — covering 3 patients (0 within standard, 3 breaches). NHS target: 85%. Data: NHS England Cancer Waiting Times, June 2026.
- What does the Breast Symptomatic pathway mean?
- The Breast Symptomatic pathway covers patients referred with breast symptoms that do not meet the 2-week-wait criteria but are nonetheless seen within the cancer waiting times framework. These patients are often referred by GPs for non-urgent assessment of breast lumps or pain.
- How does NHS Herefordshire And Worcestershire ICB's Breast Symptomatic performance compare to England?
- The England average for the 62-day Breast Symptomatic pathway was not separately published at England level in the April 2026 extract. NHS Herefordshire And Worcestershire ICB's 0.0% performance can be compared against the overall England 62-day combined standard met rate and the NHS 85% target.
- What counts as a breach of the 62-day cancer standard?
- A breach occurs when a patient does not start their first definitive cancer treatment within 62 days of the relevant referral date (2-week wait, upgrade, screening referral, or breast symptomatic). In NHS Herefordshire And Worcestershire ICB for the Breast Symptomatic pathway in April 2026, there were 3 breaches out of 3 patients.
Breast Symptomatic cancer waits in NHS Herefordshire And Worcestershire ICB — below NHS target
Only 0.0% of breast symptomatic patients in NHS Herefordshire And Worcestershire ICB met the 62-day standard in April 2026 (target: 85%). GeraClinic can connect you to a UK-registered cancer specialist while you await NHS assessment — your referral is not affected.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0. Data: Cancer Waiting Times CRS Database, April 2026. Methodology.